Beta Bionics, Inc 10-Q for FY2026 Q3
Beta Bionics, Inc. (BBNX)
10-Q
2026-10-27
For: 2026-09-30
View Original
Added on
October 27, 2026
About this 10-Q
Beta Bionics, Inc filed this 10-Q on October 27, 2026, covering the quarter ended September 30, 2026 (FY2026 Q3).
Beta Bionics reported nine-month net sales of $95.1 million, up from $68.1 million, and a net loss of (69,651), compared with (59,734), in thousands. AI summary
Headline figures
Quarter ended September 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $35.51M
- up 30.3% from $27.25M a year earlier
- Net loss
- $24.35M
- compared with a net loss of $14.21M a year earlier
- Diluted EPS
- -$0.52
- compared with -$0.33 a year earlier